Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T - PubMed (original) (raw)
. 2005 May;128(Pt 5):1016-25.
doi: 10.1093/brain/awh467. Epub 2005 Mar 9.
Affiliations
- PMID: 15758036
- DOI: 10.1093/brain/awh467
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
Radhika Srinivasan et al. Brain. 2005 May.
Abstract
Histopathological reports of multiple sclerosis and its animal models have shown evidence of a link between axonal injury in active lesions and impaired glutamate metabolism. Mature oligodendrocytes play a role in glutamate uptake to maintain glutamate homeostasis but in multiple sclerosis white matter the loss of expression of glutamate transporters in the lesion vicinity results in ineffective glutamate removal. Using a magnetic resonance spectroscopy technique that isolates the glutamate resonance at 3 T, we compared glutamate levels between normal subjects and multiple sclerosis patients in different brain areas. Metabolite concentrations (glutamate, glutamine, N-acetyl-aspartate, myo-inositol, choline, creatine) were derived from LCmodel and corrected for T1 relaxation time. Glutamate concentrations were found to be elevated in acute lesions (P = 0.02) and normal-appearing white matter (P = 0.03), with no significant elevation in chronic lesions (P = 0.77). The N-acetyl-aspartate level in chronic lesions was significantly lower (P < 0.001) than in acute lesions and normal-appearing white matter. The choline level in acute lesions was significantly higher (P < 0.001) than in chronic lesions. Evidence was also found for increased glial activity in multiple sclerosis, with significantly higher (P < 0.001) myo-inositol levels in acute lesions compared with control white matter. These in vivo results support the hypothesis that altered glutamate metabolism is present in brains of multiple sclerosis patients.
Similar articles
- Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging.
Geissler A, Lock G, Fründ R, Held P, Hollerbach S, Andus T, Schölmerich J, Feuerbach S, Holstege A. Geissler A, et al. Hepatology. 1997 Jan;25(1):48-54. doi: 10.1053/jhep.1997.v25.pm0008985263. Hepatology. 1997. PMID: 8985263 - Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo.
Bruhn H, Frahm J, Merboldt KD, Hänicke W, Hanefeld F, Christen HJ, Kruse B, Bauer HJ. Bruhn H, et al. Ann Neurol. 1992 Aug;32(2):140-50. doi: 10.1002/ana.410320205. Ann Neurol. 1992. PMID: 1324631 - Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
Tartaglia MC, Narayanan S, De Stefano N, Arnaoutelis R, Antel SB, Francis SJ, Santos AC, Lapierre Y, Arnold DL. Tartaglia MC, et al. J Neurol. 2002 Oct;249(10):1382-90. doi: 10.1007/s00415-002-0846-6. J Neurol. 2002. PMID: 12382153 - [Magnetic resonance spectroscopy in multiple sclerosis].
Viala K, Stievenart JL, Cabanis EA, Lyon-Caen O, Tourbah A. Viala K, et al. Rev Neurol (Paris). 2000 Dec;156(12):1078-86. Rev Neurol (Paris). 2000. PMID: 11139723 Review. French. - [Use of magnetic resonance imaging in the diagnosis and prognosis of multiple sclerosis].
Zivadinov R, Sepcić J. Zivadinov R, et al. Lijec Vjesn. 2006 Sep-Oct;128(9-10):295-308. Lijec Vjesn. 2006. PMID: 17128669 Review. Croatian.
Cited by
- Diffuse white matter pathology in multiple sclerosis during treatment with dimethyl fumarate-An observational study of changes in normal-appearing white matter using proton magnetic resonance spectroscopy.
Tisell A, Söderberg K, Link Y, Lundberg P, Mellergård J. Tisell A, et al. PLoS One. 2024 Oct 21;19(10):e0309547. doi: 10.1371/journal.pone.0309547. eCollection 2024. PLoS One. 2024. PMID: 39432495 Free PMC article. - Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis.
Bross M, Hackett M, Bernitsas E. Bross M, et al. Int J Mol Sci. 2020 Jun 17;21(12):4312. doi: 10.3390/ijms21124312. Int J Mol Sci. 2020. PMID: 32560364 Free PMC article. Review. - Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis.
Petracca M, Pontillo G, Moccia M, Carotenuto A, Cocozza S, Lanzillo R, Brunetti A, Brescia Morra V. Petracca M, et al. Brain Sci. 2021 Mar 9;11(3):346. doi: 10.3390/brainsci11030346. Brain Sci. 2021. PMID: 33803287 Free PMC article. Review. - Imaging of glutamate in the spinal cord using GluCEST.
Kogan F, Singh A, Debrosse C, Haris M, Cai K, Nanga RP, Elliott M, Hariharan H, Reddy R. Kogan F, et al. Neuroimage. 2013 Aug 15;77:262-7. doi: 10.1016/j.neuroimage.2013.03.072. Epub 2013 Apr 9. Neuroimage. 2013. PMID: 23583425 Free PMC article. - Glutamate excitotoxicity inflicts paranodal myelin splitting and retraction.
Fu Y, Sun W, Shi Y, Shi R, Cheng JX. Fu Y, et al. PLoS One. 2009 Aug 20;4(8):e6705. doi: 10.1371/journal.pone.0006705. PLoS One. 2009. PMID: 19693274 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical